{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:38:12Z","timestamp":1753886292459},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s10620-005-1302-0","type":"journal-article","created":{"date-parts":[[2005,2,22]],"date-time":"2005-02-22T10:53:51Z","timestamp":1109069631000},"page":"207-211","source":"Crossref","is-referenced-by-count":14,"title":["Autoimmune Hepatitis and Thyroiditis Associated with Rifampin and Pyrazinamide Prophylaxis: An Unusual Reaction"],"prefix":"10.1007","volume":"50","author":[{"given":"Omar","family":"Khokhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Gange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Clement","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"937","volume":"169","author":"E Weir","year":"2003","unstructured":"Weir E, Fisman DN: Latent tuberculosis: revised treatment guidelines. CMAJ 169:937?938, 2003","journal-title":"CMAJ"},{"key":"CR2","unstructured":"Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection?New York and Georgia, 2000. Morb Mortal Wkly Rep 50:289?291, 2001"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-137-8-200210150-00007","volume":"137","author":"RM Jasmer","year":"2002","unstructured":"Jasmer RM, Saukkonen JJ, Blumberg HM, et al. : Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: A multicenter clinical trial. Ann Intern Med 137:640?647, 2002","journal-title":"Ann Intern Med"},{"key":"CR4","unstructured":"MMWR Update: Adverse event data and revised American Thoracic Society\/CDC recommendations against the use of rifampin and pyrazinamide for the treatment of latent infection?United States, 2003, Morb Mortal Wkly Rep, 52, 735?739, 2003"},{"key":"CR5","first-page":"627","volume-title":"Autoimmune Liver Diseases","author":"J Lewis","year":"1998","unstructured":"Lewis J, Zimmerman H: Drug-induced autoimmune liver disease. In Autoimmune Liver Diseases. Krawitt EL, Wiesner RH, Nishioka (eds). New York, Elsevier Science BV, 1998, pp 627?649"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01071970","volume":"18","author":"GB Goldstein","year":"1973","unstructured":"Goldstein GB, Lam KC, Mistilis SP: Drug-induced chronic hepatitis. Am J Dig Dis 18:177?184, 1973","journal-title":"Am J Dig Dis"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0002-9343(76)90564-7","volume":"60","author":"JS Rodman","year":"1976","unstructured":"Rodman JS, Deutsch DJ, Gutman SI: Methyldopa hepatitis: A report of six cases and review of the literature. Am J Med 60:941?948, 1976","journal-title":"Am J Med"},{"key":"CR8","first-page":"53","volume":"16","author":"AJ Arranto","year":"1981","unstructured":"Arranto AJ, Sotaniemi WEA: Morphologic alteration in patients with ?-methyldopa-induced liver damage after short and long term exposure. Scand J Gastroenterol 16:53, 1981","journal-title":"Scand J Gastroenterol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7326\/0003-4819-92-1-14","volume":"92","author":"JR Sharp","year":"1980","unstructured":"Sharp JR, Ishak KG, Zimmerman HJ: Chronic active hepatitis and severe hepatitis necrosis associated with nitrofurantoin. Ann Intern Med 92:14?19, 1980","journal-title":"Ann Intern Med"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.0954-6820.1975.tb04889.x","volume":"197","author":"O Selroos","year":"1975","unstructured":"Selroos O, Edgren J: Lupus-like syndrome associated with pulmonary reaction to nitrofurantoin: Report of three cases. Acta Med Scand 197:125?129, 1975","journal-title":"Acta Med Scand"},{"key":"CR11","first-page":"208","volume":"56","author":"R Lundgren","year":"1975","unstructured":"Lundgren R, Back O, Wiman LG: Pulmonary lesions and autoimmune reactions after long term nitrofurantoin treatment. Scand J Resp Dis 56:208?212, 1975","journal-title":"Scand J Resp Dis"},{"key":"CR12","first-page":"117","volume":"67","author":"DE Hatoff","year":"1979","unstructured":"Hatoff DE, Cohen M, Schweigart DF, et al. : Nitrofurantoin: Another cause of drug-induced chronic active hepatitis?. A report of a patient with HLA-B8 antigen. Am J Med 67:117?121, 1979","journal-title":"A report of a patient with HLA-B8 antigen. Am J Med"},{"key":"CR13","first-page":"497","volume":"14","author":"S Iwarson","year":"1979","unstructured":"Iwarson S, Lindberg J, Lunden P: Nitrofurantoin induced chronic liver disease: clinical course and outcome of five cases. Scand J Gastroenterol 14:497?502, 1979","journal-title":"Scand J Gastroenterol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840080327","volume":"8","author":"BHCH Stricker","year":"1988","unstructured":"Stricker BHCH, Blok APR, Claas FHJ, et al. : Hepatic injury associated with the use of nitrofurans: A clinical pathological study of 52 cases. Hepatology 8:599?606, 1988","journal-title":"Hepatology"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/bmj.312.7024.169","volume":"312","author":"A Gough","year":"1996","unstructured":"Gough A, Chapman S, Wagstaff K, et al. : Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. Br Med J 312:169?172, 1996","journal-title":"Br Med J"},{"key":"CR16","first-page":"1641","volume":"91","author":"A Malcolm","year":"1996","unstructured":"Malcolm A, Heap TR, Eckstein RP, et al. : Minocycline induced liver injury. Am J Gastroenterol 91:1641?1643, 1996","journal-title":"Am J Gastroenterol"},{"key":"CR17","first-page":"143","volume":"92","author":"PE Goldstein","year":"1997","unstructured":"Goldstein PE, Devier J, Cremer M: Acute hepatitis and drug-related lupus induced by minocycline treatment. Am J Gastroenterol 92:143?146, 1997","journal-title":"Am J Gastroenterol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00004836-199807000-00016","volume":"27","author":"G Bhat","year":"1998","unstructured":"Bhat G, Jordan J Jr, Sokalski S, et al. : Minocycline-induced hepatitis with autoimmune features and neutropenia. J Clin Gastroenterol 27:74?75, 1998","journal-title":"J Clin Gastroenterol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1309\/KV2J-VX6Q-L95V-VDE4","volume":"114","author":"NS Goldstein","year":"2000","unstructured":"Goldstein NS, Bayati N, Silverman AL, et al. : Minocycline as a cause of drug-induced autoimmune hepatitis: Report of four cases and comparison with autoimmune hepatitis. Am J Clin Pathol 114:591?598, 2000","journal-title":"Am J Clin Pathol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archpedi.152.11.1132","volume":"152","author":"JE Teitelbaum","year":"1998","unstructured":"Teitelbaum JE, Perez-Atayde AR, Cohen M, et al. : Minocycline-related autoimmune hepatitis: Case series and literature review. Arch Pediatr Adolesc Med 152:1132?1136, 1998","journal-title":"Arch Pediatr Adolesc Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2169\/internalmedicine.42.48","volume":"42","author":"M Abe","year":"2003","unstructured":"Abe M, Furukawa S, Takayama S, et al. : Drug-induced hepatitis with autoimmune features during minocycline therapy. Intern Med 42:48?52, 2003","journal-title":"Intern Med"},{"key":"CR22","first-page":"769","volume":"13","author":"EA Pariente","year":"1989","unstructured":"Pariente EA, Hamoud A, Godfain D, et al. : Clometacin hepatitis. Retrospective study of 30 cases. A model of drug-induced autoimmune hepatitis?. Gastroenterol Clin Biol 13:769?774, 1989","journal-title":"Retrospective study of 30 cases. A model of drug-induced autoimmune hepatitis?. Gastroenterol Clin Biol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000198597","volume":"22","author":"D Pessayre","year":"1981","unstructured":"Pessayre D, Degos F, Feldmann G, et al. : Chronic active hepatitis and giant multinucleated hepatocytes in adults treated with clometacin. Digestion 22:66?72, 1981","journal-title":"Digestion"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5144\/0256-4947.2002.73","volume":"22","author":"H Al-Ashgar","year":"2002","unstructured":"Al-Ashgar H, Al-Sohaibani F, Kagevi I, et al. : Autoimmune hepatitis induced by alpha-interferon therapy in a patient with chronic myeloid leukemia. Ann Saudi Med 22:73?74, 2002","journal-title":"Ann Saudi Med"},{"key":"CR25","first-page":"415","volume":"15","author":"E Pittau","year":"1997","unstructured":"Pittau E, Bogliolo A, Tinti A, et al. : Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C. Clin Exp Rheumatol 15:415?419, 1997","journal-title":"Clin Exp Rheumatol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00535-002-1090-7","volume":"38","author":"H Sezaki","year":"2003","unstructured":"Sezaki H, Arase Y, Tsubota A, et al. : Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy. J Gastroenterol 38:493?500, 2003","journal-title":"J Gastroenterol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJM197110072851501","volume":"285","author":"TB Reynolds","year":"1971","unstructured":"Reynolds TB, Peters RL, Yamada S: Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med 285:813?820, 1971","journal-title":"N Engl J Med"},{"key":"CR28","first-page":"319","volume-title":"Drugs and the Liver","author":"TB Reynolds","year":"1975","unstructured":"Reynolds TB: Laxative liver disease. In Drugs and the Liver. Gerok W, Sickling K (eds). Stuttgart: FK Schattauer-Verlag, 1975 pp 319?325"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01071970","volume":"18","author":"GB Goldstein","year":"1973","unstructured":"Goldstein GB, Lam KC, Mistilis SP: Drug-induced chronic hepatitis. Am J Dig Dis 18:177?184, 1973","journal-title":"Am J Dig Dis"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1445-5994.1973.tb03964.x","volume":"3","author":"WGE Cooksley","year":"1973","unstructured":"Cooksley WGE, Cowen AE, Powell LW: The incidence of oxyphenisatin ingestion in active chronic hepatitis: A prospective controlled study of 29 patients. Aust NZ J Med 3:124?128, 1973","journal-title":"Aust NZ J Med"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01071970","volume":"18","author":"GB Goldstein","year":"1973","unstructured":"Goldstein GB, Lam KC, Mistilis SP: Drug-induced chronic hepatitis. Am J Dig Dis 18:177?184, 1973","journal-title":"Am J Dig Dis"},{"key":"CR32","unstructured":"Farrell GC: Drug-Induced Liver Disease. Edinburgh, Churchill Livingstone, 1994"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/0016-5085(93)90359-K","volume":"104","author":"LJ Scully","year":"1993","unstructured":"Scully LJ, Toze C, Sengar DP, et al. : Early-onset autoimmune hepatitis is associated with a C4A gene deletion. Gastroenterology 104:1478?1484, 1993","journal-title":"Gastroenterology"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1440-1746.1995.tb01106.x","volume":"10","author":"MJ Huang","year":"1995","unstructured":"Huang MJ, Liaw YF: Clinical associations between thyroid and liver diseases. J Gastroenterol Hepatol 10:344?350, 1995","journal-title":"J Gastroenterol Hepatol"},{"key":"CR35","first-page":"592","volume":"90","author":"F Giannoccaro","year":"1999","unstructured":"Giannoccaro F, Pace L, Antonaci S, et al. : Autoimmune hemolytic anemia in chronic hepatitis C virus infectioin treated with alpha-interferon: A therapy-related event or extra-hepatic immunologic manifestation?. Recenti Prog Med 90:592?594, 1999","journal-title":"Recenti Prog Med"},{"key":"CR36","first-page":"123","volume":"23","author":"V Pinol","year":"2000","unstructured":"Pinol V, Cubiella J, Navasa M, et al. : Autoimmune hepatitis associated with thyroiditis and hypophysitis. A case report. Gastroenterol Hepatol 23:123?125, 2000","journal-title":"A case report. Gastroenterol Hepatol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/rheumatology\/37.12.1349","volume":"37","author":"G Ghilardi","year":"1998","unstructured":"Ghilardi G, Gonvers JJ, So A: Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection. Br J Rheumatol 37:1349?1351, 1998","journal-title":"Br J Rheumatol"},{"key":"CR38","first-page":"1882","volume":"57","author":"M Zeniya","year":"1999","unstructured":"Zeniya M: Thyroid disease in autoimmune liver diseases. Nippon Rinsho 57:1882?1887, 1999","journal-title":"Nippon Rinsho"},{"key":"CR39","first-page":"143","volume":"65","author":"M Cindoruk","year":"2002","unstructured":"Cindoruk M, Yetkin I, Karakan T, et al. : The prevalence of autoimmune hepatitis in Hashimoto?s thyroiditis in a Turkish population. Acta Gastroenterol Belg 65:143?145, 2002","journal-title":"Acta Gastroenterol Belg"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archinte.1993.00410070050007","volume":"153","author":"RA Nordyke","year":"1993","unstructured":"Nordyke RA, Gilbert F Jr, Miyamoto LA, et al. : The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto?s thyroiditis. Arch Intern Med 153:862?865, 1993","journal-title":"Arch Intern Med"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0016-5085(86)90887-5","volume":"90","author":"E Poncin","year":"1986","unstructured":"Poncin E, Silvain C, Touchard G, et al. : Papaverine-induced chronic liver disease. Gastroenterology 90:1051?1053, 1986","journal-title":"Gastroenterology"},{"key":"CR42","first-page":"305","volume":"2","author":"R Poupon","year":"1978","unstructured":"Poupon R, Longchal C, Darnis F: Hepatite chronique associee a la prise prolongee de papaverine. Gastroenterol Clin Biol 2:305?309, 1978","journal-title":"Gastroenterol Clin Biol"},{"key":"CR43","first-page":"1899","volume":"9","author":"M Chousterman","year":"1980","unstructured":"Chousterman M, Pulik M, Perie G: Hepatite a la papaverine. Nouv Presse Med 9:1899, 1980","journal-title":"Nouv Presse Med"},{"key":"CR44","first-page":"818","volume":"5","author":"JP Desechalliers","year":"1981","unstructured":"Desechalliers JP, Lerebours E, Tilly H, et al. : Hepatite chronique compliquee de cirrhose, due a la papaverine. Gastroenterol Clin Biol 5:818, 1981","journal-title":"Gastroenterol Clin Biol"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00042737-200308000-00014","volume":"15","author":"N Pelli","year":"2003","unstructured":"Pelli N, Setti M, Ceppa P, et al. : Autoimmune hepatitis revealed by atorvastatin. Eur J Gastroenterol Hepatol 15:921?924, 2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1191\/0961203303lu313cr","volume":"12","author":"IW Graziadei","year":"2003","unstructured":"Graziadei IW, Obermoser GE, Sepp NT, et al. : Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis. Lupus 12:409?412, 2003","journal-title":"Lupus"},{"key":"CR47","first-page":"959","volume":"17","author":"M Ben-Yahia","year":"1993","unstructured":"Ben-Yahia M, Mavier P, Metreau JM, et al. : Chronic active hepatitis and cirrhosis induced by wild germander: Three cases. Gastroenterol Clin Biol 17:959?962, 1993","journal-title":"Gastroenterol Clin Biol"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7326\/0003-4819-117-2-129","volume":"117","author":"D Larrey","year":"1992","unstructured":"Larrey D, Vial T, Pauurels A, et al. : Hepatitis after germander (Teucrium Chamaedrys) administration: Another instance of herbal medicine hepatotoxicity. Ann Intern Med 117:129?132, 1992","journal-title":"Ann Intern Med"},{"key":"CR49","first-page":"191","volume-title":"Autoimmune Liver Disease","author":"WC Maddrey","year":"1991","unstructured":"Maddrey WC, Boitnott JK: Drug-induced chronic active hepatitis. In Autoimmune Liver Disease. Krawitt EL, Wiesner RH (eds). New York, Raven Press, 1991 pp 191?232"},{"key":"CR50","unstructured":"Stricker BHCh: Drug-Induced Hepatic INjury. Amsterdam, Elsevier, 1992"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00005176-198905000-00025","volume":"8","author":"G Maggiore","year":"1989","unstructured":"Maggiore G, Larizza D, Lorini R, et al. : Propylthiouracil hepatotoxicity mimicking autoimmune chronic hepatitis in a girl. J Pediatr Gastroenterol 8:547?548, 1989","journal-title":"J Pediatr Gastroenterol"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2169\/internalmedicine.42.331","volume":"42","author":"B Cui","year":"2003","unstructured":"Cui B, Abe M, Hidata S, et al. : Autoimmune hepatitis associated with Graves? disease. Intern Med 42:331?355, 2003","journal-title":"Intern Med"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/BF01316809","volume":"38","author":"LJ Scully","year":"1993","unstructured":"Scully LJ, Clarke D, Barr RJ: Diclofenac-induced hepatitis in three cases with features of autoimmune chronic active hepatitis. Dig Dis Sci 38:744?751, 1993","journal-title":"Dig Dis Sci"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/hep.1840220320","volume":"22","author":"AT Banks","year":"1995","unstructured":"Banks AT, Zimmerman HJ, Ishak KG, et al. : Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology 22:820?827, 1995","journal-title":"Hepatology"},{"key":"CR55","first-page":"2233","volume":"91","author":"MJ Sterling","year":"1996","unstructured":"Sterling MJ, Kane M, Grace ND: Pemoline induced autoimmune hepatitis. Am J Gastroenterol 91:2233?2234, 1996","journal-title":"Am J Gastroenterol"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1742-1241.2003.tb10577.x","volume":"57","author":"MA Selimoglu","year":"2003","unstructured":"Selimoglu MA, Ertekin V: Autoimmune hepatitis triggered by Brucella infection or doxycycline or both. Int J Clin Pract 57:639?641, 2003","journal-title":"Int J Clin Pract"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0168-8278(87)80039-9","volume":"5","author":"G Babany","year":"1987","unstructured":"Babany G, Larrey D, Pessayre D, et al. : Chronic active hepatitis caused by benzarone. J Hepatol 5:332?335, 1987","journal-title":"J Hepatol"},{"key":"CR58","first-page":"1048","volume":"18","author":"PH Bernard","year":"1994","unstructured":"Bernard PH, Lamouliatte H, Le Bail B: Chronic active hepatitis associated with antinuclear antibodies induced by fenofibrate. Gastroenterol Clin Biol 18:1048, 1994","journal-title":"Gastroenterol Clin Biol"},{"key":"CR59","first-page":"703","volume":"92","author":"T Kamiyama","year":"1997","unstructured":"Kamiyama T, Nouchi T, Kojima S, et al. : Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 92:703?704, 1997","journal-title":"Am J Gastroenterol"},{"key":"CR60","first-page":"1779","volume":"57","author":"M Murakami","year":"1999","unstructured":"Murakami M, Kakizaki S, Takayama H, et al. : Autoimmune thyroid disease induced by interferon therapy. Nippon Rinsho 57:1779?1783, 1999","journal-title":"Nippon Rinsho"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4158\/EP.7.1.52","volume":"7","author":"DL Ward","year":"2001","unstructured":"Ward DL, Bing-You RG: Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: Screening and monitoring recommendations. Endocr Pract 7:52?58, 2001","journal-title":"Endocr Pract"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.510260720","volume":"26","author":"G Dusheiko","year":"1997","unstructured":"Dusheiko G: Side effects of alpha interferon in chronic hepatitis C. Hepatology 26:112?21S, 1997","journal-title":"Hepatology"},{"key":"CR63","first-page":"419","volume":"57","author":"C Mekkakia-Benhabib","year":"1996","unstructured":"Mekkakia-Benhabib C, Marcellin P, Colas-Linhart N, et al. : Natural history of dysthyroidism during interferoin treatment of chronic hepatitis C. Ann Endocrinol (Paris) 57:419?427, 1996","journal-title":"Ann Endocrinol (Paris)"},{"key":"CR64","first-page":"438","volume":"13","author":"FG Garcia","year":"1996","unstructured":"Garcia FG, Marco MA, Vela J, et al. : Hypothyroidism as a complication of the treatment of hepatitis C with interferon. Ann Intern Med 13:438?440, 1996","journal-title":"Ann Intern Med"},{"key":"CR65","first-page":"480","volume":"88","author":"R Martin-Vivaldi","year":"1996","unstructured":"Martin-Vivaldi R, Nogueras F, Quintero D, et al. : Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment. with interferon. Rev Esp Enferm Dig 88:480?484, 1996","journal-title":"with interferon. Rev Esp Enferm Dig"},{"key":"CR66","first-page":"39","volume":"22","author":"A Rocco","year":"2001","unstructured":"Rocco A, Gargano S, Provenzano A, et al. : Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection. Neuroendocrinol Lett 22:39?44, 2001","journal-title":"Neuroendocrinol Lett"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0248-8663(00)88683-X","volume":"20","author":"C Broussolle","year":"1999","unstructured":"Broussolle C, Steineur MP, Bailly F, et al. : Hepatitis C virus infection and thyroid diseases. Rev Med Int 20:766?773, 1999","journal-title":"Rev Med Int"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2265.1996.751768.x","volume":"44","author":"M Marazuela","year":"1999","unstructured":"Marazuela M, Garcia-Buey L, Gonzalez-Fernandez B, et al. : Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol (Oxf) 44:635?642, 1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF02206672","volume":"10","author":"S Maccari","year":"1991","unstructured":"Maccari S, Bassi C, Giovannini AG, et al. : A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy. Clin Rheumatol 10:452?454, 1991","journal-title":"Clin Rheumatol"},{"key":"CR70","first-page":"49","volume":"22","author":"A Martocchia","year":"2001","unstructured":"Martocchia A, Labbadia G, Paoletti V, et al. : Hashimoto?s disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease. Neuroendocrinol Lett 22:49?52, 2001","journal-title":"Neuroendocrinol Lett"},{"key":"CR71","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02989219","volume":"28","author":"M Yoshikawa","year":"1993","unstructured":"Yoshikawa M, Sakamoto T, Mitoro A, et al. : Autoimmunity during alpha-interferon therapy for chronic hepatitis C. Gastroenterol Jpn 28:109?114, 1993","journal-title":"Gastroenterol Jpn"},{"key":"CR72","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0168-8278(96)80113-9","volume":"25","author":"T Okanoue","year":"1996","unstructured":"Okanoue T, Sakamoto S, Itoh Y, et al. : Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 25:283?291, 1996","journal-title":"J Hepatol"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archinte.158.13.1445","volume":"158","author":"L Fernandez-Soto","year":"1998","unstructured":"Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, et al. : Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 158:1445?1448, 1998","journal-title":"Arch Intern Med"},{"key":"CR74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF02231591","volume":"12","author":"L D?Hondt","year":"1993","unstructured":"D?Hondt L, Delannoy A, Docqueir C: Hypothyroidism and arthritis during interferon therapy. Clin Rheumatol 12:415?417, 1993","journal-title":"Clin Rheumatol"},{"key":"CR75","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1590-8658(01)80715-5","volume":"33","author":"F Morisco","year":"2001","unstructured":"Morisco F, Mazziotti G, Rotondi M, et al. : Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C. Dig Liver Dis 33:247?253, 2001","journal-title":"Dig Liver Dis"},{"key":"CR76","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/jcp.50.2.172","volume":"50","author":"M Shimizu","year":"1997","unstructured":"Shimizu M, Hirokawa M, Manabe T, et al. : Lithium associated autoimmune thyroiditis. J Clin Pathol 50:172?174, 1997","journal-title":"J Clin Pathol"},{"key":"CR77","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.0954-6820.1987.tb01271.x","volume":"221","author":"B Gudbjornsson","year":"1987","unstructured":"Gudbjornsson B, Kristinsson A, Geirsson G, et al. : Painful autoimmune thyroiditis occurring on amiadarone therapy. Acta Med Scand 221:219?220, 1987","journal-title":"Acta Med Scand"},{"key":"CR78","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF00441656","volume":"140","author":"S Nishiyama","year":"1983","unstructured":"Nishiyama S, Matsukura M, Fujimoto S, et al. : Reports of two cases of autoimmune thyroiditis while receiving anticonvulsant therapy. Eur J Pediatr 140:116?117, 1983","journal-title":"Eur J Pediatr"},{"key":"CR79","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2249.1998.00507.x","volume":"111","author":"L Takorabet","year":"1998","unstructured":"Takorabet L, Ropars A, Stasiuk L, et al. : Phenothiazine-induced increase in thyroid autoantigens and costimulatory molecules on thyroid cells: A pathophysiological mechanism for drug-induced autoimmunity?. Clin Exp Immunol 111:415?421, 1998","journal-title":"Clin Exp Immunol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-1302-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-005-1302-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-1302-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T07:49:43Z","timestamp":1683013783000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-005-1302-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["1302"],"URL":"https:\/\/doi.org\/10.1007\/s10620-005-1302-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}